ea0063oc14.1 | Sex Hormones | ECE2019
Rastrelli Giulia
, Cipriani Sarah
, Lotti Francesco
, Cellai Ilaria
, Comeglio Paolo
, Boddi Valentina
, Della Camera Pierandrea
, Gacci Mauro
, Serni Sergio
, Maggi Mario
, Vignozzi Linda
Objectives: BPH is characterised by prostate inflammation, which frequently occurs in men with metabolic syndrome (MetS). MetS is often associated with low testosterone (T). Recent evidence shows that low, rather than high, T is associated with BPH/lower urinary tract symptoms (LUTS). To evaluate if T replacement therapy (TRT) for 6 months in BPH men with MetS and low T, is able to improve LUTS and prostate inflammation.Methods: 120 men in waiting list f...